Brigham and Women's Hospital: Substance-Related Disorders trials

The registry lists 11 Substance-Related Disorders studies with Brigham and Women's Hospital as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 2 2Phase 3 2Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use DisorderCompletedNCT04982029Phase 2Results posted
• Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on BuprenorphineCompletedNCT04192370Phase 2Results posted
• Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance UseCompletedNCT03842436Phase 4Results posted
• Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)CompletedNCT03512418Phase 3Results posted
• Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.CompletedNCT03212794Not applicableResults posted
• SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use DisorderCompletedNCT05378399Phase 3
• Prevention of Opioid Use Disorder After SurgeryActive, not recruitingNCT04394559Not applicable
• Initiating Substance Use Disorder Treatment for Hospitalized Alcohol Use Disorder PatientsWithdrawnNCT04223011Not applicable
• Use of Transcranial Magnetic Stimulation to Reduce Craving for Individuals With Opioid Use Disorder Taking BuprenorphineWithdrawnNCT03653169Not applicable
• Evaluation of Yoga for Substance Use Risk Factors in a School SettingCompletedNCT01821950Not applicable
• Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid TherapyCompletedNCT00988962Not applicable